It was the best of all possible worlds in the worst of all times for biotech in 2020. What comes now?
SVB Leerink’s Geoffrey Porges ran the numbers for biotech IPOs for all of 2020 and found that the industry rang out the old year with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
